Recruiting A Study of Anti-CD19/BCMA Universal CAR-T Cell Therapy RD06-05 in Patients With Autoimmune Diseases. NCT07203404 Conditions ANCA Associated Vasculitis, ANCA-Associated Glomerulonephritis, Anti-GBM Disease, +27 more Locations Bioheng Study site — Shanghai, China View Trial Details
